Joshua B Cohen Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity
Joshua B Cohen is Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 3.22 Million shares of AMLX, which is worth approximately $16 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 18,589 shares (Common Stock) at a price of $3.2 per share, resulting in proceeds of $59,484. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.22M
0.55%
3M change
15.32%
12M change
Total Value Held
$16 Million
Joshua B Cohen Transaction History
JBC
Joshua B Cohen
Co-Chief Executive Officer
Cambridge, MA